# Joseph Fung

> Joseph Fung is a seed investor at Saltagen Ventures backing Software. See 2 investments, check sizes, portfolio and contact details. Updated Oct 2026.

- Type: Angel Investor
- Fund: [Saltagen Ventures](https://shizune.co/investors/profile/saltagen-ventures)
- Total investments: 2
- Last investment: Aug 2022
- Lead investor: 100%
- Last updated: Oct 2026
- LinkedIn: https://www.linkedin.com/in/joseph-f-26815a160/
- Website: http://saltagen.com

Joseph Fung is a seed investor at Saltagen Ventures focused on Software and DevOps. Joseph has worked at the crossroads of business execution and strategic development as an investor, entrepreneur and operator since 2002. Based in Hong Kong, Joseph manages and operates a venture capital fund house focusing on life sciences, material sciences, agricultural technology, clean technology and education. He actively spearheadspublic-private institutional support from Canada and Hong Kong to help startups successfully develop opportunities on a global scale.A notable responsibility includes being appointed by Canadian Prime Minister Justin Trudeau in ABAC to represent Canada in APEC with the support of the Minister of Trade and Global Affairs Canada. Joseph is also the Hong Kong ABLAC representative for the Asia Pacific Foundation, the innovation and technology chair for the Canadian Chamber of Commerce in Hong Kong, the advisory board member of Creative Destruction Labs Global, and the management board director of Versitech under Hong Kong University.Prior to leading Saltagen Ventures, Joseph served at Citigroup Alternative Investments and Morgan Stanley in the buy-side divisions. Thereafter, he drove the expansion of Hong Kong’s largest quad-play media company, PCCW Media, in developing their overseas content acquisition and broadcasting departments. Joseph is an alumnus of St. George’s School and Cornell University. Outside of work, Joseph enjoys spending time with his daughters, is a certified ski instructor and a rescue and technical scuba diver.

## Contacts

5 contacts available for Joseph Fung: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/joseph-fung-dcb7?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 2 | 100% |
| DevOps | 1 | 50% |
| Health Care | 1 | 50% |
| Biotechnology | 1 | 50% |
| Medical Device | 1 | 50% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Pre-Seed | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Canada | 1 | 50% |
| United States | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Sympatic | Sympatic helps owners and users of sensitive data cooperate to extract value without ever risking their data or giving away their intellectual property. We do this by creating temporary, secure compute bastions in their cloud where algorithms meet data. We let them do this safely and repeatedly, even if they have no idea how to do complex cloudDevOps. |  | Pre-Seed | Aug 04, 2022 | https://www.sympatic.com/ |
| Oncoustics AI | Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, Oncoustics does not do image recognition. Instead, Oncoustics applies AI to raw ultrasound signals from readily available handheldultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Initially targeting liver disease, a $30B global diagnostic market, Oncoustics has filed a Breakthrough Device Designation Request with the FDA for the OnX that detects liver fibrosis and the 510K is underway. Several follow-on liver products are in development. Oncoustics also has clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers. | $5M | Seed | Jul 21, 2022 | http://oncoustics.com/ |

2 of 2 investments shown.

## Co-investors
- [Creative Ventures](https://shizune.co/investors/profile/creative-ventures) — VC Fund, 2 deals together
- [Fraser Kearney Capital Corp.](https://shizune.co/investors/profile/fraser-kearney-capital-corp) — VC Fund, 1 deal together
- [NorthSpring Capital Partners](https://shizune.co/investors/profile/northspring-capital-partners) — VC Fund, 1 deal together
- [Pallasite Ventures](https://shizune.co/investors/profile/pallasite-ventures) — VC Fund, 1 deal together
- [Pool Global Partners](https://shizune.co/investors/profile/pool-global-partners) — VC Fund, 1 deal together
- [ScaleGood Fund LP (powered by TELUS)](https://shizune.co/investors/profile/scalegood-fund) — VC Fund, 1 deal together

## About Saltagen Ventures

VC Fund · Central, Hong Kong

Saltagen Ventures is an early-stage venture capital firm that invests in science and technology-based startups.Its investment strategy focuses on the verticals of edtech, biomedical technology, AI and machine learning, and media technology. They search for startups that have strong defensibility and patentable technology and empowers them to growtheir business and develop efficiencies.The firm was founded in 2017 in Central, Hong Kong by Joseph Fung.

4 contacts available at Saltagen Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Simon Lai | Chief Operating Officer | https://shizune.co/investors/profile/simon-lai |
| Yina Chan | Principal | https://shizune.co/investors/profile/yina-chan |
| Jason Chiu | Investment Committee Member | https://shizune.co/investors/profile/jason-chiu |
| Joseph Fung | Managing Partner | https://shizune.co/investors/profile/joseph-fung-dcb7 |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund

## FAQ

### What does Joseph Fung invest in?

Joseph Fung invests primarily in Software, DevOps and Health Care startups, most often at Seed and Pre-Seed stage. Most of the 2 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Joseph Fung?

Public channels for Joseph Fung include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Joseph Fung last invest?

The most recent investment recorded for Joseph Fung closed in Aug 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co